Suchergebnisse - "Knapper, Steven"

PubPharm (8)

1

FLT3 Inhibition in Acute Myeloid Leukaemia - Current Knowledge and Future Prospects

enthalten in: Current cancer drug targets | 2020

von Hogan, F. | Williams, V. | Knapper, S.

2

Elacytarabine in relapsed/refractory acute myeloid leukaemia : an evaluation of clinical efficacy, pharmacokinetics, cardiac safety and effects on lipid profile

enthalten in: Leukemia research | 2014

von Knapper, S. | Chevassut, T. | Duarte, R. | +8

3

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival

enthalten in: Blood | 2013

von Burnett, A. | Russell, N. | Hunter, A. | +9

4

The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in acute myeloid leukaemia cells

enthalten in: British journal of haematology | 2013

von Walsby, E. | Lazenby, M. | Pepper, C. | +2

5

The clinical development of FLT3 inhibitors in acute myeloid leukemia

enthalten in: Expert opinion on investigational drugs | 2011

von Knapper, S.

6

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

enthalten in: Blood | 2011

von Sato, T. | Yang, X. | Knapper, S. | +6

CommentIn: Blood. 2011 Mar 24;117(12):3247-8. - PMID 21436074

7

FLT3 inhibition in acute myeloid leukaemia

enthalten in: British journal of haematology | 2007

von Knapper, S.

8

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

enthalten in: Blood | 2006

von Knapper, S. | Burnett, A. | Littlewood, T. | +6

1
[1]